Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world
  • Posted by Pei Li Teh & Colin Tan
  • October 22, 2019
  • Events

Real world evidence research breakfast seminar

Real world evidence research breakfast seminar

We were delighted to attend and present a paper at the Tech Observer event in Singapore earlier this month

APAC Director Pei Li Teh, and Research Manager, Colin Tan, attended the event. Pei Li presented the paper ‘Inhale, exhale: How using real world data helped asthma patients breathe easier across Asia’. In her paper she demonstrated how published real world data research provided pharma companies with an in-depth understanding of asthma patients’ across Asia. The data provided the healthcare community with a tool to supply tailored communications supporting different patient types, instead of a ‘one size fits all’ approach.

read more »

  • Posted by Pei Li Teh
  • October 21, 2019
  • News

Research Partnership welcomes Jeanne Penn

Research Partnership welcomes Jeanne Penn

We are delighted to announce that Jeanne Penn has joined the Singapore office as a Senior Research Executive.

Jeanne previously worked at Cello Health Insight in New York City on the qualitative team, where she was involved in all parts of the research process, from writing proposals to delivering reports. She’s worked in various therapy areas, and has a particular interest in rare diseases and mental health. In a prior role, she co-led the first Diversity & Inclusion initiative and was awarded the Young Professionals Grant to attend the Qualitative Research Consultants Association (QRCA) conference. Jeanne graduated from Hamilton College, and interned at Hall & Partners where she was first introduced to healthcare market research.

read more »

How we helped our client understand current and future combination pricing strategies in the Multiple Myeloma market

How we helped our client understand current and future combination pricing strategies in the Multiple Myeloma market

Our client had their product  for multiple myeloma (MM) approved in several lines of therapy combined with different backbones. Their product was also being studied in some other indications with additional backbones and was anticipated to receive approval in the coming years. With several other competitive therapies available on the market, including many branded combination products, our client anticipated that payers might start considering strategies to manage combination therapies in the future. Therefore, they wanted to understand what the current and future combination pricing strategies were for oncology products, with a focus on MM and their product.

read more »

How we helped assess the asthma market landscape in emerging markets

How we helped assess the asthma market landscape in emerging markets

Our client was jointly developing a fully-human monoclonal antibody (mAB) with a number of potential immunological indications. In order to prepare for launch, primary and secondary market research was required to understand more fully the asthma landscape.

read more »

  • Posted by Marc Yates
  • September 23, 2019
  • Guides

Conducting market research for scientific publication guide

Conducting market research for scientific publication guide

Conducting and using market research for publication can be valuable for shaping opinions in healthcare. The findings can be used to influence existing perceptions, change current practices and behaviour in a particular disease area, and help both patients and physicians to make more informed decisions. Based on our expertise and experience of conducting market research for scientific publication in both developed and emerging markets across a wide range of therapy areas, we have put together a guide on how to establish medical credibility with your research.

read more »